Cary Street Partners Financial LLC bought a new stake in Rxo Inc (NYSE:RXO – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 46,000 shares of the company’s stock, valued at approximately $707,000.
A number of other large investors have also made changes to their positions in the business. AlphaQuest LLC purchased a new stake in shares of RXO during the 2nd quarter valued at $29,000. Geneos Wealth Management Inc. acquired a new position in RXO during the 1st quarter valued at about $30,000. Jones Financial Companies Lllp raised its stake in RXO by 27.0% in the third quarter. Jones Financial Companies Lllp now owns 3,298 shares of the company’s stock valued at $49,000 after buying an additional 701 shares during the last quarter. CWM LLC boosted its holdings in RXO by 141.6% in the third quarter. CWM LLC now owns 4,231 shares of the company’s stock worth $65,000 after acquiring an additional 2,480 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its holdings in RXO by 34.1% in the second quarter. Nisa Investment Advisors LLC now owns 4,576 shares of the company’s stock worth $72,000 after acquiring an additional 1,163 shares in the last quarter. 92.73% of the stock is owned by institutional investors and hedge funds.
RXO Stock Performance
RXO opened at $15.96 on Friday. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.25. Rxo Inc has a 12-month low of $10.43 and a 12-month high of $20.70. The firm has a 50 day moving average of $14.64 and a two-hundred day moving average of $15.12. The firm has a market capitalization of $2.62 billion, a PE ratio of -27.52, a P/E/G ratio of 11.21 and a beta of 1.74.
Analyst Ratings Changes
Several equities analysts have recently issued reports on RXO shares. Citigroup upped their price objective on shares of RXO from $15.00 to $18.00 and gave the company a “neutral” rating in a report on Monday, February 9th. UBS Group restated a “neutral” rating on shares of RXO in a research note on Sunday, February 8th. TD Cowen reaffirmed a “hold” rating on shares of RXO in a report on Friday, January 9th. Barclays lowered their price objective on shares of RXO from $17.00 to $15.00 and set an “overweight” rating for the company in a research note on Friday, November 7th. Finally, Wall Street Zen downgraded RXO from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Four equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, RXO presently has an average rating of “Hold” and a consensus price target of $16.33.
Check Out Our Latest Stock Report on RXO
RXO Company Profile
RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.
Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.
Recommended Stories
- Five stocks we like better than RXO
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding RXO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rxo Inc (NYSE:RXO – Free Report).
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.
